Purpose of the Procedure
- Precise identification of lymphoma types (B-cell or T-cell).
- Assisting oncologists in selecting the most effective treatment protocol.
- Detecting Minimal Residual Disease (MRD) post-treatment.
This advanced diagnostic test utilizes multi-color flow cytometry to identify specific cell surface markers, ensuring accurate lymphoma subtyping. It is crucial for developing personalized treatment plans and improving patient outcomes.
Scientific name: Lymphoma Subtyping by Flow Cytometry
A sophisticated laboratory technique using fluorescent antibodies to characterize cancer cells. It identifies specific markers on the cell surface to accurately subtype lymphomas, guiding oncology specialists toward the most effective treatments.